Simple Summary Surgery is the main treatment for thymic tumors, and multidisciplinary
treatment would benefit patients a lot. Despite numerous technological advances in the …

Thymomas are further subdivided into different types (called A, AB, B1, B2, B3 and rare
others) based upon the morphology of epithelial tumour cells, the relative proportion of the …

Mutations of the multiple endocrine neoplasia type 1 (MEN1) gene lead to loss of function of
its protein product menin. In keeping with its tumor suppressor function in endocrine tissues …

Thymic tumours are rare thoracic malignancies, that may be aggressive and difficult to treat.
The pillars of the management include pathological review, consideration of differential …

Background The prevalence of minimally invasive thymectomy (MIT) is increasing and may
have significant benefit to patients in terms of morbidity and post-operative recovery. Our aim …

Background To investigate the clinical significance of preoperative systemic immune‐
inflammation index (SII) in patients with thymoma who underwent radical resection. Methods …

Thymoma is a disease with malignant potential, which has a recurrence rate after complete
resection ranging from 5 to 50%. Multiple studies on the risk factors, treatment or prognosis …

Postoperative radiotherapy may significantly improve survival of patients undergoing
surgery for thymic carcinoma; however, the quality of available evidence is low. We …

Background There is no standard treatment for recurrent thymic epithelial tumors. Although
the efficacy has not been validated based on the large series studies, surgical resection is …

This meta-analysis was designed to determine the effect of surgical and nonsurgical
approaches on 5-year and 10-year overall survival (OS) in patients with recurrent thymoma …